Feb 17

Accutane at fault for inadequate warnings

Category: Uncategorized,

LaRoche, the drugmaker responsible for Accutane, has been slapped with a $25 million judgment against it for inadequate labeling of its popular acne drug. This is the latest in a series of personal injury judgments against the embattled manufacturer blaming them for chronic ailments such as inflammatory bowel disease suffered after using the oral drug. While Accutane, or isotretinoin, was highly effective and often used as a last resort in treating patients with severe acne who failed to respond to other treatments, it also had significant potential side effects requiring frequent monitoring.

In addition to being associated with birth defects, there were other serious effects that apparently were not spelled out clearly enough by the manufacturer according to these juries. Reportedly, Accutane has been unavailable from LaRoche as of last year.


This is yet another example of what we believe will be a backlash against drug manufacturers who today advertise directly to consumers day and night while paying little attention to properly educating them as patients. As for acne, all but the most severe sufferers can benefit from daily topical treatments that include exfoliants, topical retinoids (vitamin A derivatives), and other effective ingredients that do not carry the risk for these types of systemic side effects. See our post on JolieMD or our JolieMD site for more details on effective skincare.

Be Sociable, Share!
No comments

No Comments

Leave a comment